Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc73.

Amyloid precursor protein (APP) is a secretory membrane-bound protein that undergoes restrictive proteolysis and degradation with a short life span in the constitutive secretory pathway or in the endosomal/lysosomal compartment. The degradation machinery, including cellular trafficking and the restrictive cleavage of APP, is poorly understood. To gain further insight into ...
the intracellular degradation mechanism of APP, we searched for effector proteins that interact with APP. We found that a cytosolic molecular chaperon, Hsc73, effectively interacts with the cytoplasmic domain of APP in the presence of proteasome inhibitors. Hsc73 binds to the cytoplasmic domain near the post-transmembrane region of APP and not to the KFERQ-related sequence, KFFEQ, at the C-terminal tail that is assumed to be the selective targeting signal for lysosomal proteolysis. The amounts of Hsc73 that bind to several APP species such as those found in pathological Familial Alzheimer's disease (FAD), Swedish, or Dutch type mutation, are almost identical, suggesting that an abnormal conformation around the secretory cleavage site or a pathological imbalance in APP processing are not irrelevant to the efficiency of Hsc73 binding.
Mesh Terms:
Alzheimer Disease, Amino Acid Sequence, Amyloid beta-Protein Precursor, Animals, Base Sequence, COS Cells, Cysteine Endopeptidases, Cysteine Proteinase Inhibitors, DNA Primers, HSC70 Heat-Shock Proteins, HSP70 Heat-Shock Proteins, Heat-Shock Proteins, Humans, Hydrolysis, Molecular Sequence Data, Multienzyme Complexes, Mutagenesis, Site-Directed, Proteasome Endopeptidase Complex, Protein Binding, Tumor Cells, Cultured
Biochem. Biophys. Res. Commun.
Date: Jan. 27, 1999
Download Curated Data For This Publication
219320
Switch View:
  • Interactions 1